The global COVID-19 pandemic, which disproportionately affected cardiovascular patients, changed hospital processes, treatment goals, and pharmaceutical use, and the most prescribed medicines were antiplatelets.
The findings support an MAI-based audit against the guideline version in force as a tool for quality control and risk stratification of high cardiometabolic-burden populations should be a standing element of pandemic preparedness.
Mohammed H. Abutaleb, M. Asiri, S. Menachery et al.· Healthcare· 0 citations
Background: Polypharmacy has become an important challenge in geriatric care owing to the high prevalence of multimorbidity and age-related physiological changes that increase susceptibility to medication-related harm. Hospitalized older adults are particularly vulnerable to adverse drug reactions, drug–drug interactio...
Arpit Verma, S. Prajapati, Brijesh Kumar Gupta et al.· International Journal of Dru...· 0 citations
Background: Drug-related problems (DRPs) are highly prevalent among critically ill patients in intensive care units (ICUs) and may negatively influence clinical outcomes. Pharmacist-led interventions play a pivotal role in detecting and resolving DRPs; however, their implementation and acceptance vary across healthcare...
Sarah Mousavi, M. Karimi, S. Farsaei· Archives of Anesthesia and C...· 0 citations
Elderly inpatients with polypharmacy and cardiovascular comorbidities represent the highest risk group for preventable DRPs, and proactive clinical pharmacist integration through daily ward rounds and medication reconciliation achieves a high rate of problem resolution, enhancing inpatient drug safety.
Anamika S. Patne, Shivakumar S. Ladde, Prajakta N. Sakhare et al.· PAIN, JOINTS, SPINE· 0 citations
Background: Because the liver drives the clearance of most medicines, any decline in hepatic function reshapes drug handling and leaves patients open to drug-related problems (DRPs). We set out to map the drug utilization pattern, characterise the DRPs, and identify the risk factors linked to hepatic impairment in admi...
Prajwal S. Hallur, Aftabhusain Dhalayat, Vivek Kumar et al.· International Journal of Res...· 0 citations
Background: Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality worldwide. Pharmacological management of CVDs requires long-term administration of multiple medications, increasing the risk of adverse drug reactions (ADRs). ADRs contribute significantly to hospital admissions, prolonged ho...
Ranita Kumari, Komal Sharma· Genetics and Molecular Resea...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.